MIAMI, June 17, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, including hypoplastic left heart syndrome (HLHS) and Alzheimer's disease, today announced that it will participate in the Virtual Life Sciences Investor Forum taking place June 20, 2024. Details for the Company's participation:  Fireside Chat Date:Fireside Chat Time:Thursday, June 20, 2024 ...